MedTrace Logo

Suture-mediated Closure System Following Endovascular Peripheral Arterial Procedures

NCT05899478 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 135

Last updated 2025-06-25

No results posted yet for this study

Summary

The purpose of this study is to evaluate the effectiveness and safety of the suture-mediated closure system produced by Suzhou Hengrui Hongyuan Medical Technology Co., Ltd. following endovascular peripheral arterial procedures.

Conditions

  • Percutaneous Intervention Via Femoral Artery

Interventions

DEVICE

Tyknot® Suture-Mediated Closure System

Arterial closure to ensure hemostasis at femoral artery puncture points

DEVICE

Perclose® ProGlide Suture-Mediated Closure System

Arterial closure to ensure hemostasis at femoral artery puncture points

Sponsors & Collaborators

  • Suzhou Hengruihongyuan Medical Technology Co. LTD

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-01
Primary Completion
2024-01-01
Completion
2024-04-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05899478 on ClinicalTrials.gov